Sun Pharmaceutical Industries, a leading Indian multinational pharmaceutical company, is expecting a positive trajectory for the current fiscal year. According to the company's Managing...
Novo Nordisk CEO Lars Fruergaard Jorgensen revealed the company's strategy for launching its popular obesity treatment Wegovy in markets where its older weight-loss drug...
Introduction: Pfizer Inc. faces a challenging entry into the new year as its shares hover near a decade-low, signaling a turbulent 2023. Despite the...
Novo Nordisk A/S, the maker of the popular weight-loss medication Ozempic, is set to invest €2.1 billion ($2.3 billion) in expanding its production facilities...